Quick Overview: Humanity's healthcare needs are evolving faster than most of us can keep up with. And while many seem to be awakening to the ... Alnylam Pharmaceuticals CEO Yvonne Greenstreet discusses why RNAI can be used to treat an array of diseases, the company's ... GlaxoSmithKline takes on Pfizer and Biogen battles Celgene in this healthcare edition of Industry Focus. This podcast was ...
Episode 11 From Biopharma To - Detailed Overview & Context
Humanity's healthcare needs are evolving faster than most of us can keep up with. And while many seem to be awakening to the ... Alnylam Pharmaceuticals CEO Yvonne Greenstreet discusses why RNAI can be used to treat an array of diseases, the company's ... GlaxoSmithKline takes on Pfizer and Biogen battles Celgene in this healthcare edition of Industry Focus. This podcast was ... Launch Your Biotech Episode 11: Intellectual Property Drug policy debate today is like a wetland. It's the heart of the ecosystem that has to be preserved at all costs — or else we lose ... There's a bird behind you! Join Dr Rowan Moore on an uncharacteristically hot day in Dublin, Ireland where she met Dr Jonathan ...
Based in Toronto, Ontario, Vasomune Therapeutics is a clinical stage Our guests this week are Ilya Pharma CEO and co-founder Evelina Vågesjö and chief financial officer Oskar Lund; Miguel ... Discover biosimilars research, resources, patient stories and more in
